Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) is one of the best affordable biotech stocks to invest in now. Rigel ...

This biotech is a leader in the treatment of cystic fibrosis, and that’s helped earnings explode higher over the years. The ...

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is one of the best affordable biotech stocks to invest in now. On September 8, ...

Outlining the key touchpoints for embracing change and opportunity in the “messy, tough—and fun” R&D-to-commercial transition ...

A Boston biotech with an FDA-approved drug is laying off half of its staff just eight months after its last round of layoffs, ...

The life science industry, including companies that work in biotechnology, pharmaceuticals and medical devices, is among the ...

IBD's proprietary rating tracks share price movement with a 1 (worst) to 99 (best) score. The grade shows how a stock's p ...

New data from the HS-OBTAIN Phase IIa study (clinical study identifier: show that treatment with brivekimig led to clinically-meaningful improvements in the primary endpoint of hidradenitis ...

The future of health is no longer confined to white coats and petri dishes. It is being wired into the skull and slipped onto ...

The United States has been intensifying scrutiny on Chinese innovative drugs entering the global market. By strengthening Committee on Foreign Investment in the United States (CFIUS) reviews and ...

Mumbai: Lupin has announced that the U.S. Food and Drugs Administration (USFDA) has closed the inspection with six ...

As of the market close on 17 September 2025, Cohance shares traded at around ₹967.70 per share, down 2.2%. This price is well ...